These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 25706291)

  • 1. Clinical features and survival of lung cancer patients with pleural effusions.
    Porcel JM; Gasol A; Bielsa S; Civit C; Light RW; Salud A
    Respirology; 2015 May; 20(4):654-9. PubMed ID: 25706291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant Pleural Effusion: Still a Long Way to Go.
    Meriggi F
    Rev Recent Clin Trials; 2019; 14(1):24-30. PubMed ID: 30514193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Talc pleurodesis improves survival of patients with malignant pleural effusions: case-control study.
    Korsic M; Badovinac S; Cucevic B; Janevski Z
    Wien Klin Wochenschr; 2015 Dec; 127(23-24):963-9. PubMed ID: 25860847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of malignant pleural effusions.
    Sahn SA
    Monaldi Arch Chest Dis; 2001 Oct; 56(5):394-9. PubMed ID: 11887496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions.
    Kasapoglu US; Arınç S; Gungor S; Irmak I; Guney P; Aksoy F; Bandak D; Hazar A
    Clin Respir J; 2016 Nov; 10(6):791-799. PubMed ID: 25764010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A propensity-matched comparison of pleurodesis or tunneled pleural catheter in patients undergoing diagnostic thoracoscopy for malignancy.
    Freeman RK; Ascioti AJ; Mahidhara RS
    Ann Thorac Surg; 2013 Jul; 96(1):259-63: discussion 263-4. PubMed ID: 23673067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
    Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
    Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
    Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
    Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality Gaps and Comparative Effectiveness of Management Strategies for Recurrent Malignant Pleural Effusions.
    Ost DE; Niu J; Zhao H; Grosu HB; Giordano SH
    Chest; 2018 Feb; 153(2):438-452. PubMed ID: 28864054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality among patients with pleural effusion undergoing thoracentesis.
    DeBiasi EM; Pisani MA; Murphy TE; Araujo K; Kookoolis A; Argento AC; Puchalski J
    Eur Respir J; 2015 Aug; 46(2):495-502. PubMed ID: 25837039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
    Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
    Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleural Effusions in Diffuse Large B-Cell Lymphoma: Clinical and Prognostic Significance.
    Porcel JM; Cuadrat I; García-Cerecedo T; Pardina M; Bielsa S
    Lung; 2019 Feb; 197(1):47-51. PubMed ID: 30506166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant pleural effusions because of lung cancer.
    Porcel JM
    Curr Opin Pulm Med; 2016 Jul; 22(4):356-61. PubMed ID: 27055072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cell block method increases the diagnostic yield in exudative pleural effusions accompanying lung cancer.
    Köksal D; Demırağ F; Bayız H; Koyuncu A; Mutluay N; Berktaş B; Berkoğlu M
    Turk Patoloji Derg; 2013; 29(3):165-70. PubMed ID: 24022305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of malignant pleural effusions.
    Fenton KN; Richardson JD
    Am J Surg; 1995 Jul; 170(1):69-74. PubMed ID: 7793501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing approaches to the management of malignant pleural effusions.
    Porcel JM; Lui MM; Lerner AD; Davies HE; Feller-Kopman D; Lee YC
    Expert Rev Respir Med; 2017 Apr; 11(4):273-284. PubMed ID: 28271728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast and Lung Effusion Survival Score Models: Improving Survival Prediction in Patients With Malignant Pleural Effusion and Metastasis.
    Molina S; Martinez-Zayas G; Sainz PV; Leung CH; Li L; Grosu HB; Adachi R; Ost DE
    Chest; 2021 Sep; 160(3):1075-1094. PubMed ID: 33852918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of Prognostic Factors and Clinical Characteristics for Patients with Limited Stage Small Cell Lung Cancer with Pleural Effusion].
    Xu K; Wang Y; Qi J; Zhao L; Wang P
    Zhongguo Fei Ai Za Zhi; 2018 Jan; 21(1):16-23. PubMed ID: 29357968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different expression of FoxM1 in human benign and malignant pleural effusion.
    Tang Z; Li H; Zhu H; Bai C
    Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of malignant pleural effusions.
    Heffner JE
    Respirology; 2008 Jan; 13(1):5-20. PubMed ID: 18197908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.